PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 4,165.00
+50.00 (1.22%)
Dec 17, 2025, 3:16 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 78.49 billion as of December 17, 2025. Its market cap has decreased by -8.99% in one year.
Market Cap
78.49B
Enterprise Value
83.83B
Revenue
171.66B
Ranking
n/a
PE Ratio
666.54
Stock Price
4,165.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 78.49B, an increase of 620.58%. That is a compound annual growth rate of 6.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 77.26B | 4.16% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | 165.78B | 123.51% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 40.87T |
| ALTEOGEN | 23.16T |
| ABL Bio | 10.47T |
| SK Biopharmaceuticals | 10.43T |
| Yuhan | 8.73T |
| LigaChem Biosciences | 6.41T |
| HLB Co., Ltd. | 6.33T |